Anthony Realini, MD
Enriched profileProfessor and Vice Chair for Clinical Research, Department of Ophthalmology and Visual Sciences · West Virginia University School of Medicine
Anthony Realini is Professor and Vice Chair for Clinical Research, Department of Ophthalmology and Visual Sciences at West Virginia University School of Medicine. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 2 Sept 2026
Anthony Realini, M.D., is Professor and Vice Chair for Clinical Research, Department of Ophthalmology and Visual Sciences at West Virginia University School of Medicine / WVU Eye Institute. The public record shows 26 publications with 1,586 citations (h-index 17), centered on Glaucoma. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 5 companies, 4 NIH-funded awards (2006–2026).
- Top research focus: Glaucoma
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 2 Sept 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- African Glaucoma Laser Trial
Sponsor: West Virginia University
- 12-Month Stability of Diurnal IOP Control on Cosopt
Sponsor: West Virginia University
Industry payments
Updated 2 Sept 2026
5 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- Sight Sciences, Inc.Program year20242 payments
- Ocular Therapeutix, Inc.Program year20234 payments$25,040openpaymentsdata.cms.gov ↗
- Oyster Point Pharma, Inc.Program year20233 payments$25,000openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
90.1%Prostaglandin Analog51.9%Latanoprost100%Part D≥37 patientsCarbonic Anhydrase Inhibitor18.4%Dorzolamide-Timolol100%Part D≥20 patientsCardiovascular
9.9%Beta blocker9.9%Timolol Maleate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 2 Sept 2026
4 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
- Clarifying the Optimal Application of SLT Therapy (COAST)
West Virginia University
FY2024$1,491,247UG1EY031654 - Clarifying the Optimal Application of SLT Therapy (COAST)
West Virginia University
FY2023$353,963UG1EY031654
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Common Variant in MIR182 Is Associated With Primary Open-Angle Glaucoma in the NEIGHBORHOOD Consortium
Digital Commons@Becker (Washington University School of Medicine)
2020
Online presence
Updated 2 Sept 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/anthony-realini-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 2 Sept 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →directory.hsc.wvu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.hsc.wvu.edu ↗
- Board Certified
American Board of Ophthalmology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.hsc.wvu.edu ↗
Editorial & leadership roles
journal and society appointments- Section Editor
"Clinician Scientist's Corner," Glaucoma Today
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →glaucomatoday.com ↗
Awards & honors
honors on the public record- Realini Clinical Research Center at WVU Eye Institute named in his honor
recognizing a $150,000 gift toward the new outpatient building
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wvumedicine.org ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore